No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2804 |
4. Check minimum number of eventsNone |
2804 |
5. Include endpointsNone |
2804 |
6. Filter based on genotype QC (FinnGen only) |
2804 |
Control definitions (FinnGen only)
- Control exclude
- J10_PLEURA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- J90-J94
- Name in latin
- Pneumothorax
Similar endpoints
↥List of similar endpoints to
Pneumothorax
based on the number of shared cases.
Similar with more cases:
- Other diseases of pleura
- Diseases of the respiratory system
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 22531 | 5868 | 16399 |
| Only index persons | 17810 | 4882 | 12928 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.38 | 0.17 | 0.46 |
| Only index persons | 0.41 | 0.18 | 0.49 |
| Median age at first event (years) | |||
| Whole population | 50.37 | 56.14 | 48.09 |
| Only index persons | 43.39 | 52.37 | 40.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2804 | 806 | 1998 |
| Unadjusted period prevalence (%) | 0.71 | 0.27 | 0.88 |
| Median age at first event (years) | 57.75 | 51.42 | 60.30 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2504
- Matched controls
- 25041
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
16384.0
323.0
1061
*
J93.8
ICD-10 Finland
Other pneumothorax
+∞
323.0
545
*
51299
ICD-8 Finland
Spontaneous pneumothorax
+∞
323.0
321
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
85.2
323.0
584
89
J93.9
ICD-10 Finland
Pneumothorax, unspecified
7388.3
323.0
584
*
J93.0
ICD-10 Finland
Spontaneous tension pneumothorax
+∞
300.2
282
*
5120A
ICD-9 Finland
Pneumothorax, Spontaneous tension pneumothorax
+∞
287.1
270
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
447.7
209.7
207
5
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.4
177.1
768
2271
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
5.6
171.2
566
1246
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
4.8
163.8
627
1617
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
5.3
141.6
481
1072
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
136.5
1368
7356
GD1AD
NOMESCO Finland
Thorax CT examination
8.0
135.5
326
457
UGC12
NOMESCO Finland
Flexible bronchoscopy
5.5
130.3
425
897
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
7.2
129.7
338
533
J96.1
ICD-10 Finland
Chronic respiratory failure
+∞
119.7
114
*
R03BB04
ATC
tiotropium bromide; inhalant
4.2
112.2
487
1369
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
16.7
102.8
168
107
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
95.9
880
4209
GDB01
NOMESCO Finland
Thoracoscopic resection of bullae of lung
+∞
90.1
86
*
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
5.7
89.8
276
531
GAC47
NOMESCO Finland
Endoscopic partial decortication of pleura
290.9
83.1
84
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
7.3
83.0
210
311
J94.8
ICD-10 Finland
Other specified pleural conditions
813.7
80.9
79
*
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
7.1
79.5
204
308
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
4.5
64.9
246
590
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
5.4
64.2
204
404
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
12.5
64.2
118
99
R06.0
ICD-10 Finland
Dyspnoea
2.3
62.1
694
3524
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.5
60.9
595
2820
J93
ICD-10 Finland
Pneumothorax
315.1
60.6
61
*
130
Kela drug reimbursment
Malignant tumour
3.2
59.7
346
1188
S27.0
ICD-10 Finland
Traumatic pneumothorax
14.4
58.7
101
73
J43.9
ICD-10 Finland
Emphysema, unspecified
8.8
56.5
125
149
H02AB06
ATC
prednisolone; systemic
2.0
54.9
1182
7846
TGA30
NOMESCO Finland
Thoracocentesis
59.6
54.7
64
11
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
7.1
54.7
139
206
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
14.1
52.0
90
66
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
25.0
51.7
73
30
R03AC02
ATC
salbutamol; inhalant
1.9
50.7
1216
8307
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.5
50.6
254
777
R4110
NOMESCO Finland
Physiotherapy
2.1
50.0
713
3979
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
19.3
49.0
75
40
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.5
47.5
411
1798
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.9
46.7
202
545
5841
FHL
Trocar rhostomy
102.0
45.9
50
5
N02AA05
ATC
oxycodone; systemic
2.4
44.5
442
2073
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
83.3
44.0
49
6
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
43.7
494
2463
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.7
41.8
322
1313
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
6.5
41.6
111
176
JN4BD
NOMESCO Finland
Extensive body CT
2.5
40.5
350
1522
ZXD05
NOMESCO Finland
Urgent procedure
1.9
40.4
813
5098
J96.0
ICD-10 Finland
Acute respiratory failure
142.3
39.8
42
*
R03DA04
ATC
theophylline; systemic, rectal
3.1
39.7
232
791
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
39.2
563
3100
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
39.0
687
4097
J01MA14
ATC
moxifloxacin; systemic
2.8
38.8
277
1076
J01MA12
ATC
levofloxacin; systemic
2.1
38.5
542
2959
Z51.5
ICD-10 Finland
Palliative care
3.2
38.1
214
708
WX892
NOMESCO Finland
Monitored bed care
2.9
37.9
251
931
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
7.3
35.9
88
124
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.9
35.8
234
859
H02AB02
ATC
dexamethasone; systemic
2.6
35.1
276
1134
R95
ICPC
Chron obstructive pulmonary disease
4.8
34.9
120
259
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.1
34.4
113
232
R03AC12
ATC
salmeterol; inhalant
3.4
34.4
173
528
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
6.7
33.9
88
135
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
6.4
33.6
90
144
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
32.5
297
1320
XG410
NOMESCO Finland
Flow-volume spirometry
3.8
32.4
141
382
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
29.1
32.0
43
15
N02AX02
ATC
tramadol; systemic, rectal
1.7
31.6
1028
7350
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
8.4
31.0
69
84
5822
FHL
Exploratory thoracotomy and small procedure (eg lung suture)
42.8
30.9
38
9
A03FA01
ATC
metoclopramide; systemic, rectal
2.0
30.2
475
2680
5128X
ICD-9 Finland
Pneumothorax, Other spontaneous pneumothorax
+∞
29.2
28
*
GAC34
NOMESCO Finland
Endoscopic mechanical pleurodesis
+∞
29.2
28
*
J86.9
ICD-10 Finland
Pyothorax without fistula
9.3
29.2
61
67
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
29.0
460
2598
GAC37
NOMESCO Finland
Endoscopic chemical pleurodesis
295.2
28.8
29
*
A02BC02
ATC
pantoprazole; systemic
1.6
28.6
1457
11617
TGC00
NOMESCO Finland
Bronchial lavation
4.9
28.6
95
198
Z3231
NOMESCO Finland
Registered nurse
1.8
28.6
671
4327
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.0
28.6
173
601
R03BB01
ATC
ipratropium bromide; inhalant
3.2
28.5
161
534
GDC00
NOMESCO Finland
Lobectomy of lung
10.4
27.5
54
53
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
16.0
27.2
44
28
Z2221
NOMESCO Finland
Medical doctor
1.7
27.1
635
4079
GDB00
NOMESCO Finland
Resection of bullae of lung
+∞
27.1
26
*
L01CA04
ATC
vinorelbine; systemic
11.3
27.1
51
46
JN4AD
NOMESCO Finland
Body CT examination
2.5
27.0
219
912
Z3226
NOMESCO Finland
Physiotherapist
1.9
26.7
451
2598
A04AA01
ATC
ondansetron; systemic, rectal
2.9
26.6
174
638
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
26.4
403
2233
R02
ICPC
Shortness of breath/dyspnoea
2.2
25.8
292
1432
N03AX16
ATC
pregabalin; oral
1.8
25.8
521
3187
GAA31
NOMESCO Finland
Thoracoscopy
18.8
25.7
39
21
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
10.0
25.5
51
52
J45.1
ICD-10 Finland
Nonallergic asthma
2.7
25.2
180
694
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.2
25.1
136
439
J98.1
ICD-10 Finland
Pulmonary collapse
58.6
25.0
29
5
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
25.0
838
5934
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
5.2
24.9
78
153
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.5
24.4
117
344
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
4.5
24.1
88
203
R03AK07
ATC
formoterol and budesonide; inhalant
1.9
23.5
413
2402
WF004
NOMESCO Finland
Palliative radiotherapy
4.7
23.4
80
173
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
10.6
23.3
45
43
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
4.9
23.2
77
161
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
22.8
629
4206
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
22.7
1079
8269
GDA21
NOMESCO Finland
Thoracoscopic excision of lesion of lung
45.4
22.4
27
6
H02AB07
ATC
prednisone; oral
1.9
22.2
347
1933
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
7.0
22.2
55
80
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.4
22.2
191
820
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
6.0
22.1
61
103
WX250
NOMESCO Finland
Intercostal blockade
29.3
21.9
29
10
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
22.4
21.7
31
14
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
7.2
21.1
51
72
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
5.0
20.6
67
138
N80.89
ICD-10 Finland
Endometriosis with other specified or multiple localization
30.3
20.6
27
9
WZC30
NOMESCO Finland
Teaching
1.9
20.5
315
1743
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.8
20.4
87
233
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
20.4
387
2301
Z94.2
ICD-10 Finland
Lung transplant status
32.8
20.2
26
8
GDG10
NOMESCO Finland
Bilateral transplantation of lung
48.4
20.2
24
5
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
20.2
437
2713
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
10.4
19.6
38
37
ZX120
NOMESCO Finland
Intravenous
2.1
19.3
233
1170
Z2446
NOMESCO Finland
Social worker
2.4
19.3
169
730
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.7
19.3
138
535
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
31.5
19.3
25
8
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
22.7
19.1
27
12
J96.9
ICD-10 Finland
Respiratory failure, unspecified
55.4
18.9
22
*
GAC00
NOMESCO Finland
Biopsy of pleura
100.8
18.6
20
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
3.2
18.4
100
325
N02BE01
ATC
paracetamol; systemic, rectal
1.5
18.4
1918
17051
WX402
NOMESCO Finland
General anaesthesia
1.8
18.4
342
2017
GAC46
NOMESCO Finland
Partial decortication of pleura
44.3
18.2
22
5
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.4
18.1
154
657
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
8.4
17.9
39
47
GDB10
NOMESCO Finland
Wedge resection of lung
18.2
17.8
27
15
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
20.2
17.7
26
13
GAC40
NOMESCO Finland
Pleurodesis with decortication
+∞
17.7
17
*
J94.2
ICD-10 Finland
Haemothorax
181.2
17.5
18
*
GAC36
NOMESCO Finland
Chemical pleurodesis
181.2
17.5
18
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
17.5
383
2374
C45.0
ICD-10 Finland
Mesothelioma of pleura
42.3
17.3
21
5
J45.8
ICD-10 Finland
Mixed asthma
3.3
17.2
86
263
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
5.5
17.2
51
95
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
6.6
17.2
44
68
348
Kela drug reimbursment
Roflumilast
25.8
16.9
23
9
ZXE00
NOMESCO Finland
One hour or less
1.5
16.9
838
6362
R03AC13
ATC
formoterol; inhalant
2.6
16.8
127
508
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.3
16.6
152
674
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
16.5
626
4477
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.6
16.1
116
452
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
6.4
16.1
42
67
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.1
16.0
87
284
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
15.8
266
1517
N05CF01
ATC
zopiclone; oral
1.5
15.7
711
5274
R03BA01
ATC
beclometasone; inhalant
1.8
15.7
306
1827
A04AA02
ATC
granisetron; systemic, transdermal
2.4
15.6
132
564
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
5.7
15.5
44
78
J94.9
ICD-10 Finland
Pleural condition, unspecified
160.9
15.5
16
*
J01AA02
ATC
doxycycline; systemic
1.4
15.5
1713
15059
R28
ICPC
Limited function/disability (R)
5.2
15.3
47
92
XG466
NOMESCO Finland
Sleep oxymetry
3.1
15.1
86
288
S22.4
ICD-10 Finland
Multiple fractures of ribs
3.4
14.9
72
216
R52.0
ICD-10 Finland
Acute pain
3.1
14.8
80
261
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
9.2
14.7
30
33
M05BA04
ATC
alendronic acid; oral
2.2
14.6
159
763
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
14.5
572
4106
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
2.7
14.4
101
387
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
27.3
14.3
19
7
R81
ICPC
Pneumonia
2.8
14.2
92
337
R03DX07
ATC
roflumilast; oral
22.4
14.2
20
9
J43.8
ICD-10 Finland
Other emphysema
14.5
14.0
23
16
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.2
14.0
145
681
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
6.1
13.9
37
61
XX3DW
NOMESCO Finland
Time consuming IT work
1.9
13.8
224
1256
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
3.5
13.8
64
187
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
8.6
13.7
29
34
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
13.6
323
2041
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
13.6
658
4922
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
75.5
13.6
15
*
J98.2
ICD-10 Finland
Interstitial emphysema
+∞
13.5
13
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
13.5
806
6278
C03CA01
ATC
furosemide; systemic
1.4
13.2
685
5188
R03BA05
ATC
fluticasone; inhalant
1.6
13.2
343
2222
R03AC18
ATC
indacaterol; inhalant
6.1
13.2
35
58
ZXA05
NOMESCO Finland
Left side
1.5
13.2
553
4014
R04.2
ICD-10 Finland
Haemoptysis
2.5
13.1
100
403
JN4CD
NOMESCO Finland
Very extensive body CT
2.5
13.0
104
432
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
5.4
13.0
38
71
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
4.5
12.9
45
102
R03BA02
ATC
budesonide; inhalant
1.6
12.8
345
2253
R03AC03
ATC
terbutaline; inhalant
1.7
12.8
270
1648
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
3.9
12.7
52
137
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
5.8
12.7
35
61
ZXA00
NOMESCO Finland
Right side
1.5
12.6
587
4346
J43.1
ICD-10 Finland
Panlobular emphysema
70.2
12.6
14
*
J92.9
ICD-10 Finland
Pleural plaque without asbestos
70.2
12.6
14
*
R4190
NOMESCO Finland
Nutritional therapy
3.0
12.6
73
251
GAC41
NOMESCO Finland
Endoscopic pleurodesis with decortication
+∞
12.5
12
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.5
12.5
100
416
R84
ICPC
Malignant neoplasm bronchus/lung
9.3
12.5
25
27
1503
FHL
Thoracoscopy and other therapeutic procedure
130.6
12.4
13
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.3
12.3
118
537
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
8.5
12.3
26
31
WX872
NOMESCO Finland
Intensive care
2.2
12.2
126
594
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
12.1
383
2600
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.4
12.1
58
174
L04AA06
ATC
mycophenolic acid; systemic
4.0
12.1
48
123
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
8.7
12.0
25
29
A28
ICPC
Limited function/disability NOS
1.6
12.0
332
2182
S22.3
ICD-10 Finland
Fracture of rib
2.0
12.0
161
844
C07AB07
ATC
bisoprolol; oral
1.4
11.9
1053
8726
N07BA03
ATC
varenicline; oral
2.3
11.8
110
493
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
3.0
11.8
67
226
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.1
11.7
125
598
R03AK08
ATC
formoterol and beclometasone; inhalant
2.7
11.7
77
287
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
7.7
11.6
26
34
RS221
NOMESCO Finland
NA
4.2
11.6
43
104
GAC01
NOMESCO Finland
Endoscopic biopsy of pleura
65.2
11.6
13
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
11.6
276
1745
Z31.5
ICD-10 Finland
Genetic counselling
2.6
11.3
83
331
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.2
11.2
111
513
B01AB05
ATC
enoxaparin; parenteral
1.4
10.9
611
4671
J01CA04
ATC
amoxicillin; systemic
1.3
10.8
1698
15267
J01FA06
ATC
roxithromycin; oral
1.4
10.8
800
6414
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.9
10.8
63
219
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
10.8
146
771
N06AX11
ATC
mirtazapine; oral
1.4
10.7
602
4603
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
5.3
10.6
31
59
AA1AD
NOMESCO Finland
CT of head and brain
1.4
10.5
511
3796
J43.2
ICD-10 Finland
Centrilobular emphysema
11.2
10.5
19
17
N02AA01
ATC
morphine; systemic, rectal
3.8
10.4
43
116
A10BA02
ATC
metformin; oral
0.7
10.3
343
4723
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
5.8
10.3
28
49
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
23.4
10.2
14
6
A06AD11
ATC
lactulose; oral
1.5
10.2
336
2302
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
5.0
10.2
31
62
R13
ICD-10 Finland
Dysphagia
1.9
10.1
143
768
WX110
NOMESCO Finland
Local anesthesy
1.3
10.1
1374
12035
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.1
10.0
110
534
ZX108
NOMESCO Finland
Inhalation
6.5
10.0
25
39
WX002
NOMESCO Finland
Sedation and analgesia
1.5
9.9
403
2888
WX725
NOMESCO Finland
Noninvasive ventilation
2.3
9.9
89
395
191
Kela drug reimbursment
Erlotinib
16.8
9.9
15
9
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.6
9.8
237
1505
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.9
9.8
152
844
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
3.7
9.7
41
113
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
3.3
9.6
46
140
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
9.6
144
787
N80.3
ICD-10 Finland
Endometriosis of pelvic peritoneum
4.1
9.4
35
86
9050/3-C38.4
ICD-O-3
Mesothelioma, malignant of pleura, NOS
100.4
9.4
10
*
5862
FHL
Decortication (removal of visceral or parietal pleura)
30.1
9.4
12
*
5119X
ICD-9 Finland
Pleurisy, Unspecified pleural effusion
+∞
9.4
9
*
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.1
9.4
106
523
L03AA02
ATC
filgrastim; parenteral
2.7
9.2
59
219
WX882
NOMESCO Finland
High dependency care
2.5
9.0
66
265
J47
ICD-10 Finland
Bronchiectasis
3.2
9.0
44
137
TGD00
NOMESCO Finland
Needle biopsy of lung
6.5
8.9
22
34
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
8.9
220
1401
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.9
8.9
51
176
127
Kela drug reimbursment
Transplant complication
3.5
8.8
39
112
WF002
NOMESCO Finland
Radical radiotherapy
1.9
8.7
126
683
R05CB01
ATC
acetylcysteine; inhalant, oral
2.9
8.7
50
172
9052/3-C38.4
ICD-O-3
Epithelioid mesothelioma, malignant of pleura, NOS
50.1
8.7
10
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.5
8.5
66
273
A31.0
ICD-10 Finland
Pulmonary mycobacterial infection
9.0
8.5
17
19
103
Kela drug reimbursment
Diabetes, insulin-treated
0.7
8.5
347
4636
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.4
8.5
68
285
1BA04
NOMESCO Finland
NA
20.1
8.5
12
6
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
3.3
8.5
41
127
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.9
8.4
111
584
GAC33
NOMESCO Finland
Mechanical pleurodesis
+∞
8.3
8
*
R11
ICD-10 Finland
Nausea and vomiting
1.8
8.3
143
823
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
3.3
8.3
40
124
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
8.2
205
1314
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
3.1
8.2
42
136
A01AB09
ATC
miconazole; local oral
1.7
8.1
162
973
R03BA08
ATC
ciclesonide; inhalant
1.8
8.1
141
811
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
5.7
8.1
22
39
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.0
8.1
94
470
WW200
NOMESCO Finland
Immunization
2.5
8.0
59
237
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.7
8.0
151
895
WW500
NOMESCO Finland
Blood transfusion
2.1
8.0
84
403
S27.2
ICD-10 Finland
Traumatic haemopneumothorax
13.1
7.9
13
10
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.2
7.8
77
359
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
0.5
7.7
68
1277
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.6
7.7
105
1754
A07AA02
ATC
nystatin; oral
1.8
7.7
117
647
A02BC01
ATC
omeprazole; systemic
1.3
7.7
557
4409
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.0
7.6
90
454
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
2.1
7.6
79
379
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
5.7
7.5
20
35
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
7.4
637
5166
5869
FHL
Other measure in this category
80.3
7.4
8
*
J91
ICD-10 Finland
Pleural effusion in conditions classified elsewhere
80.3
7.4
8
*
GAC43
NOMESCO Finland
Total decortication of pleura
80.3
7.4
8
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.9
7.4
101
537
GD2CT
NOMESCO Finland
Cytology of the lungs with CT guidance
13.4
7.4
12
9
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.9
7.4
109
599
B01AB10
ATC
tinzaparin; parenteral
1.8
7.3
125
716
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.5
7.3
54
218
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
3.9
7.2
28
73
R50.9
ICD-10 Finland
Fever, unspecified
1.5
7.2
281
1993
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
15.8
7.2
11
7
J80
ICD-10 Finland
Adult respiratory distress syndrome
7.3
7.2
16
22
155
Kela drug reimbursment
Afatinib and gefitinib
30.1
7.1
9
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
3.2
7.0
35
112
M05BX04
ATC
denosumab; parenteral
2.0
7.0
82
413
J02AC03
ATC
voriconazole; systemic
10.0
7.0
13
13
N05BA04
ATC
oxazepam; oral
1.4
7.0
456
3542
N80.9
ICD-10 Finland
Endometriosis, unspecified
4.3
7.0
24
56
R09.1
ICD-10 Finland
Pleurisy
3.2
7.0
34
107
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.0
7.0
37
124
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
3.8
7.0
27
71
X57
ICD-10 Finland
Unspecified privation
2.4
6.9
53
221
GDA20
NOMESCO Finland
Excision of lesion of lung
7.5
6.9
15
20
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
6.9
872
7429
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
13.8
6.9
11
8
JAH00
NOMESCO Finland
Laparotomy
2.3
6.9
58
252
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
6.9
428
3303
H02AB04
ATC
methylprednisolone; systemic
1.5
6.9
260
1835
ZY010
NOMESCO Finland
Hospital outpatient
2.0
6.9
82
414
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
3.7
6.9
28
77
J01MA02
ATC
ciprofloxacin; systemic
1.3
6.8
825
6985
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.7
6.8
151
937
XG460
NOMESCO Finland
Short time oxymetry
2.6
6.8
45
173
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
5.0
6.8
20
40
N80
ICD-10 Finland
Endometriosis
9.3
6.8
13
14
WX600
NOMESCO Finland
Single shot through catheter
3.3
6.8
32
99
L01EB04
ATC
osimertinib; oral
40.1
6.8
8
*
341
Kela drug reimbursment
Afatinib and gefitinib
40.1
6.8
8
*
3004
Kela drug reimbursment
Osimertinib
40.1
6.8
8
*
RS220
NOMESCO Finland
NA
3.3
6.7
31
94
P01AB01
ATC
metronidazole; oral, rectal
1.3
6.7
681
5637
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.9
6.7
88
464
J15.8
ICD-10 Finland
Other bacterial pneumonia
4.1
6.7
24
59
WX730
NOMESCO Finland
Conventional respirator
2.8
6.7
40
145
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.7
6.6
214
2983
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.1
6.6
72
353
RS230
NOMESCO Finland
NA
5.2
6.6
19
37
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
3.2
6.6
32
101
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
4.0
6.6
24
60
R05CB03
ATC
carbocisteine; oral
2.3
6.6
54
234
I50.9
ICD-10 Finland
Heart failure, unspecified
1.4
6.5
303
2222
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
2.8
6.5
38
135
A06AH03
ATC
naloxegol; oral
3.6
6.5
27
76
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
2.9
6.4
35
120
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.1
6.4
68
329
3A006
NOMESCO Finland
NA
70.0
6.4
7
*
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.6
6.4
147
921
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
3.2
6.4
31
98
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.8
6.3
98
546
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
6.6
6.3
15
23
WX722
NOMESCO Finland
PEEP
1.8
6.3
100
562
J01DB01
ATC
cefalexin; oral
1.3
6.3
1739
16131
TKC20
NOMESCO Finland
Catheterisation of bladder
1.6
6.3
162
1048
J01FF01
ATC
clindamycin; systemic
1.3
6.3
519
4172
Z72.0
ICD-10 Finland
Tobacco use
2.3
6.3
52
226
M48.5
ICD-10 Finland
Collapsed vertebra, not elsewhere classified
9.3
6.3
12
13
A02BC05
ATC
esomeprazole; systemic
1.3
6.3
752
6351
AK3
HP
BLTX (both lung transplants)
+∞
6.2
6
*
E42
ICD-10 Finland
Marasmic kwashiorkor
26.7
6.2
8
*
5823
FHL
Lung avobiopsy and wedge resection
26.7
6.2
8
*
R03BB07
ATC
umeclidinium bromide; inhalant
4.3
6.2
21
49
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.6
6.2
142
892
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.3
6.1
478
3811
XX4BW
NOMESCO Finland
NA
7.7
6.1
13
17
ZX090
NOMESCO Finland
Other technic of radiotherapy
2.2
6.1
58
267
D01
ICPC
Abdominal pain/cramps general
1.6
6.1
161
1047
TK800
NOMESCO Finland
Hemodialysis
2.3
6.1
50
216
J86.00
ICD-10 Finland
Empyema with broncho-pleural fistula
12.5
6.1
10
8
WX726
NOMESCO Finland
High-flow oxygen therapy
12.5
6.1
10
8
R03BB02
ATC
oxitropium bromide; inhalant
3.6
6.1
25
70
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
6.0
379
2924
WW200
SPAT
NA
0.6
6.0
70
1210
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.9
6.0
86
469
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
254
352
7.84
175.65
2.1
1.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
174
167
11.04
159.74
1.7
1.2
g/l
33.7
28.1
4.49
162
140
(40768806) Pleura Pathology biopsy report
150
114
13.85
159.64
1.7
1.2
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
112
55
21.17
148.27
1.3
1.2
u/l
13.1
15.1
0.19
105
49
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
311
639
5.35
144.87
3.5
2.6
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
156
158
10.40
137.75
1.7
1.2
e6/l
6369.9
1510.5
0.88
122
100
(3036782) Glucose [Moles/volume] in Pleural fluid
126
110
11.95
122.93
1.5
1.2
mmol/l
5.3
7.4
4.26
115
105
(3028308) Erythrocytes [#/volume] in Pleural fluid
139
141
10.32
122.49
1.6
1.2
e6/l
64903.2
12625.7
1.50
92
78
(3012441) Differential panel - Pleural fluid
132
129
10.69
119.39
1.7
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
121
128
9.83
103.32
1.7
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
1121
6351
2.27
91.75
5.9
4.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
151
244
6.48
89.88
1.2
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
142
240
6.18
80.78
3.4
2.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
578
2567
2.58
80.48
10.8
7.2
mmol/l
1.4
0.9
2.32
500
1957
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
576
2561
2.57
79.97
10.9
7.2
kpa
5.3
5.0
6.60
551
2431
(3027801) Oxygen [Partial pressure] in Arterial blood
575
2561
2.57
79.50
10.9
7.2
kpa
11.3
12.2
3.81
551
2435
(3035880) pH of Pleural fluid
75
59
13.03
77.85
1.3
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
637
3032
2.42
75.97
2.6
2.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1394
9240
2.01
70.03
11.2
10.3
inr
1.3
1.3
0.90
355
2582
(3012095) Magnesium [Moles/volume] in Serum or Plasma
686
3497
2.27
69.05
6.0
3.1
mmol/l
0.8
0.8
1.14
641
3274
(4035726)
419
1705
2.71
68.85
1.5
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
698
3628
2.23
66.72
2.5
1.8
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
513
2343
2.46
66.16
11.5
7.5
%
94.7
95.7
2.76
492
2246
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
317
1163
2.95
63.07
11.4
9.4
mmol/l
24.6
24.0
2.19
304
1085
(3033658) Prothrombin time (PT) actual/Normal
927
5478
2.03
62.67
6.0
3.9
%
88.0
86.0
1.64
915
5349
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
92
132
7.17
61.11
2.7
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
120
237
5.24
57.73
3.3
2.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1109
7152
1.91
56.82
8.1
5.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
352
1451
2.63
55.77
7.7
4.8
—
—
—
0
0
(4010399)
343
1411
2.63
54.51
1.7
1.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1539
11117
1.85
54.28
10.0
6.0
umol/l
10.7
12.4
11.79
1466
10561
(3018677) aPTT in Platelet poor plasma by Coagulation assay
648
3521
2.09
53.83
2.3
2.0
s
30.5
29.9
1.55
632
3420
(3022096) Basophils/100 leukocytes in Blood
1359
9469
1.84
53.63
8.6
5.9
%
0.6
0.7
3.10
1304
8798
(3014576) Chloride [Moles/volume] in Serum or Plasma
563
2908
2.17
53.31
10.4
6.6
mmol/l
104.4
104.5
0.28
544
2825
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
44
26
17.18
53.17
1.3
1.2
%
31.0
30.4
0.03
34
17
(3006504) Eosinophils/100 leukocytes in Blood
1387
9764
1.83
52.57
8.6
5.9
%
2.7
2.9
1.92
1329
9057
(3019069) Monocytes/100 leukocytes in Blood
1391
9811
1.83
52.29
8.9
6.2
%
8.7
8.8
1.04
1333
9142
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
137
329
4.33
52.02
2.1
1.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
453
2165
2.30
51.74
12.5
8.0
g/l
123.1
121.8
0.61
441
2082
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
165
458
3.77
51.36
2.4
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1333
9322
1.82
51.16
7.0
4.9
g/l
33.6
35.3
17.88
1256
8636
(3001604) Monocytes [#/volume] in Blood
1444
10373
1.81
50.42
8.2
5.6
e9/l
0.7
0.6
7.26
1259
8902
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
500
2514
2.20
50.41
2.5
1.7
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
1449
10433
1.80
50.07
8.2
5.6
e9/l
0.0
0.0
0.27
1265
8962
(3002030) Lymphocytes/100 leukocytes in Blood
1407
10043
1.80
50.05
8.7
6.0
%
24.4
27.1
14.52
1341
9314
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
502
2535
2.19
50.03
4.1
4.0
u/l
244.4
243.0
0.08
479
2379
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
497
2502
2.20
49.91
2.4
1.7
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
421
1988
2.32
49.31
9.5
6.8
mmol/l
1.3
1.4
1.75
401
1911
(3019198) Lymphocytes [#/volume] in Blood
1466
10668
1.78
48.15
8.3
5.7
e9/l
1.8
1.9
1.06
1299
9312
(3018010) Neutrophils/100 leukocytes in Blood
1384
9907
1.78
48.06
8.4
5.8
%
60.3
57.8
10.57
1325
9233
(3013115) Eosinophils [#/volume] in Blood
1477
10776
1.78
48.04
8.7
5.8
e9/l
0.2
0.2
0.07
1303
9397
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
164
483
3.54
46.72
2.4
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
115
264
4.50
46.23
2.0
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
115
278
4.27
43.26
2.2
1.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1337
9683
1.73
42.79
9.8
5.9
mmol/l
1.2
1.2
1.80
1254
8747
(3013650) Neutrophils [#/volume] in Blood by Automated count
1593
12113
1.73
42.66
13.9
8.6
e9/l
4.6
4.2
7.22
1410
10531
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
290
1235
2.50
42.49
15.1
9.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1662
12856
1.72
41.15
8.5
4.7
mmol/l
6.6
6.9
4.19
1608
12081
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
129
352
3.79
41.11
2.3
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
302
1333
2.42
40.88
4.9
3.1
mmol/l
2.7
1.5
6.19
244
946
(3009343) pH of Capillary blood
310
1390
2.38
40.50
5.0
3.1
ph
7.4
7.4
1.01
40
158
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
313
1411
2.37
40.40
5.0
3.1
kpa
5.3
5.1
5.11
297
1290
(3044640) Blood type and Crossmatch panel - Blood
997
6751
1.74
39.88
3.1
2.5
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
44
45
9.92
38.34
1.7
1.2
%
59.1
54.4
0.24
35
30
(3000991) Gas panel - Venous blood
383
1923
2.15
38.01
11.6
8.0
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
409
2112
2.10
37.71
10.7
6.9
mmol/l
9.6
10.4
1.48
397
2000
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
96
226
4.36
37.38
2.5
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
110
290
3.91
36.81
1.7
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
102
255
4.11
36.70
1.7
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
985
6766
1.70
36.67
4.5
3.2
u/l
31.4
37.9
1.68
934
6429
(3037692) Legionella sp identified in Specimen by Organism specific culture
46
54
8.64
36.15
2.4
1.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1414
10700
1.65
36.02
10.9
6.7
mmol/l
1.2
1.2
2.04
1250
9021
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
308
1455
2.25
35.46
12.7
8.7
%
0.6
0.7
0.62
303
1443
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
410
2171
2.04
35.17
4.2
4.2
ug/l
42.2
26.8
0.33
344
1796
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
88
203
4.44
35.17
4.9
3.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
795
5201
1.74
35.03
3.0
2.4
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
307
1465
2.23
34.46
12.6
8.6
%
1.4
1.3
0.13
302
1455
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
694
4400
1.77
33.99
4.9
3.8
ng/l
413.6
718.2
0.72
575
3599
(3006184) Hemoglobin [Mass/volume] in Capillary blood
141
467
3.13
33.21
3.0
2.0
g/l
125.7
129.6
0.77
70
339
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
690
4422
1.74
32.31
2.1
1.7
mg/l
1.6
1.4
0.81
551
3363
(44790048)
87
213
4.18
32.20
2.8
1.5
—
—
—
0
0
(44806118)
87
213
4.18
32.20
2.8
1.5
—
—
—
0
0
(44790047)
87
213
4.18
32.20
2.8
1.5
—
—
—
0
0
(44790049)
87
213
4.18
32.20
2.8
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
788
5259
1.69
31.73
10.7
6.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
231
1016
2.39
31.30
4.7
3.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
197
807
2.55
31.12
3.4
2.7
u/ml
0.3
0.3
1.01
97
454
(3018418) pH of Serum or Plasma
900
6256
1.65
30.80
5.5
3.9
ph
7.4
7.4
1.07
164
1185
(3003458) Phosphate [Moles/volume] in Serum or Plasma
493
2917
1.84
30.02
8.1
5.8
mmol/l
1.1
1.0
0.99
460
2705
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
121
401
3.11
28.47
1.8
1.7
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
333
1763
2.01
28.25
2.4
2.5
g/l
64.3
66.7
5.81
307
1603
(3000492) Spirometry study
348
1909
1.94
26.58
2.0
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
211
963
2.29
26.19
2.6
1.9
ug/l
2.1
2.8
0.29
179
843
(3002582) Erythrocytes [#/volume] in Urine
938
6805
1.57
25.85
4.0
3.3
e6/l
149.5
84.4
0.32
754
5315
(3000494) Fungus identified in Specimen by Culture
415
2431
1.83
25.81
2.4
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1275
9911
1.53
25.58
4.7
4.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1927
16453
1.55
24.23
12.2
7.3
u/l
81.7
79.4
1.35
1844
15473
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
25
22
11.46
24.02
3.5
2.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
374
2171
1.83
23.85
4.7
3.7
kpa
5.9
5.8
1.20
352
2091
(3015235) Bicarbonate [Moles/volume] in Capillary blood
143
574
2.57
23.54
4.9
2.6
mmol/l
25.7
24.5
2.61
133
497
(3002032) Base excess in Venous blood by calculation
371
2163
1.82
23.29
4.7
3.7
mmol/l
2.2
1.7
1.63
303
1682
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
146
597
2.52
23.13
1.9
1.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
48
95
5.12
23.08
4.6
3.6
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
271
1439
1.98
22.63
12.5
6.8
mmol/l
25.6
24.2
6.99
255
1336
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
222
1098
2.11
22.52
4.7
4.1
mmol/l
24.5
23.9
1.78
200
980
(1616796) Gas panel - Central venous blood
122
463
2.71
22.47
5.7
3.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
50
105
4.83
22.46
1.6
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
50
105
4.83
22.46
1.6
1.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
123
470
2.69
22.35
5.7
3.8
mmol/l
2.4
2.4
0.05
90
300
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
185
861
2.23
21.88
4.9
3.4
mmol/l
25.7
24.6
4.95
177
798
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
255
1341
1.99
21.87
1.7
1.4
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
125
490
2.62
21.60
4.8
2.4
kpa
7.6
8.0
1.61
118
445
(3015377) Calcium [Moles/volume] in Serum or Plasma
940
7033
1.51
21.57
5.4
3.3
mmol/l
2.4
2.3
0.34
823
6118
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
256
1357
1.98
21.46
2.0
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
54
129
4.25
20.71
1.6
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
836
6150
1.51
20.61
3.9
3.2
e6/l
0.8
0.4
1.20
651
4703
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
142
605
2.42
20.60
3.2
2.4
g/l
3.8
3.7
0.24
137
573
(3014891) Appearance of Pleural fluid
21
18
11.75
20.47
1.8
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
1011
7756
1.47
20.16
4.7
3.7
e6/l
86.7
116.7
0.88
774
5666
(3010421) pH of Blood
133
558
2.45
19.96
5.7
3.5
ph
7.4
7.4
0.06
119
462
(3002256) Pathology report gross observation
430
2728
1.68
19.87
1.3
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
110
422
2.67
19.86
16.1
5.1
iu/ml
616.8
4276.3
0.46
37
57
(36304419) Bacteria [Presence] in Urine
810
5964
1.50
19.72
3.7
3.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
303
1749
1.82
19.51
3.2
2.1
nmol/l
383.1
373.5
0.31
281
1601
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1087
8496
1.46
19.51
4.9
3.8
ng/l
40.0
62.1
2.03
830
6197
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
115
456
2.59
19.43
1.7
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
115
456
2.59
19.43
1.7
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
275
1542
1.87
19.43
1.9
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
335
2011
1.76
18.87
2.3
2.1
g/l
0.2
0.2
0.03
311
1866
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
19
16
11.95
18.69
2.0
1.2
%
5.0
11.8
—
12
5
(3026782) Osmolality of Urine
630
4447
1.54
18.53
3.2
2.8
mosm/kgh2o
550.0
568.4
1.38
555
3792
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
329
1975
1.75
18.52
2.8
2.5
u/l
43.9
64.1
0.34
288
1688
(3005719) IgG [Mass/volume] in Serum or Plasma
265
1492
1.86
18.46
3.4
2.6
g/l
10.3
10.7
0.75
246
1368
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
882
6677
1.47
18.44
3.5
2.6
u/l
58.6
58.1
0.12
817
6167
(3021589) Normoblasts [#/volume] in Blood
1159
9236
1.43
18.43
14.5
9.3
e9/l
0.0
0.0
0.72
917
7554
(3052851) Hemolysis interference index of Serum or Plasma
139
617
2.32
18.40
4.2
3.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
871
6586
1.47
18.29
3.7
3.0
ng/l
1764.5
1682.1
0.17
779
5633
(3035637) Corticotropin [Mass/volume] in Plasma
72
230
3.19
18.10
1.8
1.6
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
23
7
33.11
17.95
1.1
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
660
4740
1.51
17.81
3.0
2.6
e6/l
4.5
4.3
0.10
596
4183
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
381
2409
1.67
17.71
3.2
2.8
umol/l
10.0
9.5
0.13
332
2132
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
68
214
3.23
17.52
2.5
1.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
138
627
2.26
17.30
2.9
2.1
%
89.9
90.3
0.07
128
600
(40767503) Oxygen content in Capillary blood by calculation
108
440
2.51
17.28
4.0
2.3
%
15.1
16.4
2.25
54
222
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
322
1958
1.73
17.28
3.7
2.8
ng/l
298.5
227.0
0.50
296
1793
(3007853) Bacteria identified in Skin by Aerobe culture
394
2529
1.65
17.25
2.1
1.8
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
58
167
3.53
17.18
1.6
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
64
197
3.30
17.10
2.6
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
102
409
2.55
16.88
4.9
2.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
175
886
2.04
16.65
1.6
1.3
u/ml
23.4
10.8
—
7
23
(46235355) HIV 1 and 2 tests - Meaningful Use set
467
3151
1.58
16.61
2.0
1.8
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
46
116
4.01
16.47
1.6
2.3
%
16.0
15.8
0.03
26
55
(40768804) Tissue Pathology biopsy report
1029
8147
1.42
16.42
2.5
2.1
—
—
—
0
0
(3019977) pH of Arterial blood
47
121
3.93
16.36
2.1
2.9
ph
7.4
7.4
0.08
17
25
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
164
823
2.05
15.99
3.8
3.3
u/ml
2117.0
3940.6
0.23
140
710
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
555
3939
1.51
15.60
4.4
3.0
mmol/l
2.5
2.4
7.18
493
3444
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
159
799
2.05
15.45
3.4
2.2
ug/l
492.6
528.0
0.08
152
756
(3022948) Iron [Moles/volume] in Serum or Plasma
500
3486
1.53
15.25
2.9
2.5
umol/l
11.7
13.1
4.09
458
3223
(4062490)
53
157
3.42
15.07
1.3
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
56
172
3.30
15.05
2.4
2.2
e9/l
1.1
1.1
0.34
38
90
(3005322) IgE [Units/volume] in Serum or Plasma
199
1094
1.88
14.91
1.5
1.3
u/ml
278.8
230.4
0.36
184
1002
(3028271) Lactate [Moles/volume] in Capillary blood
84
326
2.63
14.89
2.3
1.8
mmol/l
1.7
1.7
0.28
84
317
(3024354) Oxygen [Partial pressure] in Venous blood
292
1801
1.69
14.81
3.8
3.0
kpa
4.5
4.5
0.03
273
1727
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
123
571
2.21
14.67
2.8
2.3
%
196.6
194.1
0.10
113
544
(3024891) Influenza virus A+B Ag [Presence] in Specimen
117
534
2.24
14.55
1.4
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
26
45
5.82
14.46
1.3
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
43
114
3.82
14.40
1.7
2.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
55
173
3.22
14.24
1.4
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
24
39
6.20
14.20
1.9
1.5
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
73
272
2.73
14.03
1.3
1.6
g/l
0.8
0.9
0.09
55
217
(3024139) IgG subclass 3 [Mass/volume] in Serum
51
155
3.33
13.96
1.3
1.2
g/l
0.4
0.4
0.15
36
113
(3027135) IgG subclass 1 [Mass/volume] in Serum
51
155
3.33
13.96
1.3
1.2
g/l
7.7
6.8
0.65
36
114
(3028192) IgG subclass 2 [Mass/volume] in Serum
51
155
3.33
13.96
1.3
1.2
g/l
2.5
3.1
1.49
36
113
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
440
3044
1.53
13.81
3.0
2.5
%
22.1
23.4
1.02
373
2607
(3026250) Tacrolimus [Mass/volume] in Blood
37
91
4.11
13.73
38.9
34.8
ug/l
8.0
7.2
1.05
32
83
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
505
3602
1.49
13.68
3.6
3.0
e6/l
1.7
1.5
0.30
285
2019
(3026008) Bacteria identified in Urine by Culture
769
5959
1.40
13.27
3.3
3.1
—
—
—
0
0
(3036489) Thrombin time
149
777
1.97
13.08
2.5
1.9
s
21.3
21.5
0.19
135
701
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
75
294
2.59
13.07
6.0
6.6
mg/l
11.1
11.8
0.64
67
271
(3031040) Bacteria [#/volume] in Urine by Automated count
1586
13800
1.34
12.86
5.2
4.4
e6/l
2399.9
1849.6
0.09
46
232
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1901
20822
0.73
12.82
4.2
4.5
mmol/l
4.4
4.5
1.30
1725
19233
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
171
943
1.87
12.70
2.3
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1952
21279
0.73
12.61
4.7
5.0
mmol/l
2.6
2.7
2.71
1769
19526
(3047181) Lactate [Moles/volume] in Blood
136
696
2.00
12.60
12.6
6.5
mmol/l
1.4
1.4
0.07
121
613
(3002179) Metamyelocytes/100 leukocytes in Blood
256
1595
1.67
12.46
4.9
3.7
%
0.8
0.6
0.59
93
365
(3004789) Transferrin [Mass/volume] in Serum or Plasma
455
3235
1.49
12.43
3.0
2.5
g/l
2.2
2.3
2.97
420
3001
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1886
20652
0.73
12.39
4.2
4.4
mmol/l
1.4
1.4
2.07
1698
18943
(3028026) IgM [Mass/volume] in Serum or Plasma
201
1176
1.76
12.30
2.0
1.8
g/l
1.2
1.4
1.34
186
1072
(3017181) Myelocytes/100 leukocytes in Blood
277
1779
1.62
11.95
5.2
3.9
%
1.1
0.9
0.80
123
527
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1780
19606
0.75
11.69
5.7
6.0
mmol/mol
39.4
40.3
4.61
1607
18118
(3042733) HLA Ab [Presence] in Serum
28
63
4.48
11.66
4.5
5.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
26
55
4.76
11.65
2.7
1.5
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
43
132
3.29
11.63
2.5
2.0
e6/l
567.3
579.7
0.04
37
114
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
79
336
2.39
11.62
5.6
2.7
u/ml
654.3
2728.8
—
8
22
(3027945) Reticulocytes/100 erythrocytes in Blood
385
2696
1.50
11.27
2.8
2.5
%
1.7
1.7
0.39
337
2368
(3021879) Hepatitis B virus core Ab [Presence] in Serum
226
1410
1.66
10.93
1.5
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
46
153
3.04
10.92
1.3
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
83
373
2.26
10.79
3.8
3.5
%
62.0
58.3
1.49
83
373
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
153
859
1.83
10.76
2.1
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1830
19978
0.76
10.44
3.9
4.0
mmol/l
1.3
1.3
0.42
1647
18203
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
27
65
4.18
10.35
3.7
2.0
u/ml
780.9
39886.4
—
9
12
(3024471) HLA-A [Type]
27
65
4.18
10.35
1.0
1.0
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
81
368
2.24
10.28
3.2
3.3
%
1.5
1.7
0.13
66
279
(3007930) Methemoglobin/Hemoglobin.total in Blood
162
939
1.77
10.26
10.9
5.4
%
0.9
0.9
0.38
151
877
(3021440) Promyelocytes/100 leukocytes in Blood
256
1676
1.58
10.18
5.3
3.9
%
0.1
0.1
0.20
116
481
(3030905) Polymorphonuclear cells [#/volume] in Blood
79
359
2.24
10.02
3.5
3.3
e9/l
4.9
4.3
1.28
79
359
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
119
632
1.92
9.96
1.4
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
59
236
2.53
9.94
2.7
3.2
%
58.6
57.3
0.15
38
150
(3022217) INR in Platelet poor plasma by Coagulation assay
435
3195
1.43
9.87
21.4
27.5
inr
1.3
1.4
0.73
50
448
(4015189)
22
47
4.71
9.76
3.2
1.8
—
—
—
0
0
(3039000) Anion gap in Blood
101
511
2.01
9.73
14.8
7.5
mmol/l
10.5
11.5
2.26
90
453
(3018572) Chloride [Moles/volume] in Blood
101
511
2.01
9.73
14.8
7.5
mmol/l
104.0
105.5
3.53
90
453
(3037522) Nuclear Ab [Titer] in Serum
349
2467
1.47
9.70
1.4
1.3
titre
389.3
461.9
0.59
67
506
(3023183) Ammonium ion [Moles/volume] in Plasma
99
500
2.02
9.59
2.5
2.9
umol/l
34.0
36.3
0.28
79
413
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
821
6701
1.32
9.54
2.9
2.1
u/l
186.8
254.2
1.79
775
6289
(3017143) Hepatitis C virus Ab [Presence] in Serum
317
2207
1.49
9.50
1.9
1.6
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
161
953
1.73
9.49
10.9
5.4
%
1.7
1.6
0.56
150
890
(21494815) CD4 cells/100 lymphocytes in Specimen
41
139
2.98
9.46
1.9
2.4
%
30.3
46.6
—
6
19
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
91
449
2.06
9.40
1.3
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2262
21130
1.36
9.37
28.7
14.6
mg/l
30.4
26.2
7.57
2020
16847
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
329
2316
1.48
9.33
4.7
3.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
501
3806
1.39
9.32
3.3
2.9
e6/l
1.0
1.0
0.09
282
2212
(3010375) cycloSPORINE [Mass/volume] in Blood
30
85
3.56
9.22
35.7
25.0
ug/l
146.9
112.4
1.24
20
69
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
144
834
1.77
9.17
2.2
1.9
u/l
41.9
39.1
0.75
125
722
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
99
510
1.98
9.09
1.7
1.4
g/l
0.2
0.2
0.01
93
488
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
99
511
1.97
9.04
2.3
2.0
mg/l
10.1
11.6
1.31
92
463
(3024928) Oxygen saturation in Venous blood
96
493
1.98
8.90
2.8
3.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
25
64
3.93
8.86
1.0
1.1
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
216
1407
1.58
8.78
4.5
3.2
g/l
128.0
128.8
0.18
209
1371
(3037467) Urinalysis macro (dipstick) panel - Urine
1612
14474
1.27
8.47
5.2
4.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
100
534
1.90
8.29
1.7
1.4
g/l
1.1
1.2
0.96
95
509
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
51
210
2.46
8.15
3.0
2.7
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
23
59
3.92
8.15
1.4
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
298
2113
1.46
8.12
2.6
2.4
ug/l
7.8
7.6
0.10
258
1854
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
46
181
2.57
8.08
1.8
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
46
181
2.57
8.08
1.8
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
46
181
2.57
8.08
1.8
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
232
1565
1.53
8.08
5.5
3.9
%
0.0
0.4
0.98
98
392
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
109
605
1.83
8.03
2.3
2.2
g/l
0.0
0.0
0.00
98
557
(3013707) Erythrocyte sedimentation rate by Westergren method
1697
15383
1.26
7.99
5.3
3.9
mm/h
14.7
12.1
7.61
1576
14154
(3018405) Lactate [Moles/volume] in Arterial blood
139
830
1.71
7.98
5.9
3.6
mmol/l
1.4
1.4
0.24
132
816
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
114
643
1.81
7.97
2.3
2.2
g/l
0.1
0.0
0.43
103
592
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
107
599
1.82
7.68
2.3
2.2
g/l
0.0
0.0
0.00
98
556
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
79
402
1.99
7.57
1.7
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
30
97
3.12
7.55
2.2
2.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
56
251
2.26
7.43
3.8
3.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
684
5603
1.29
7.43
2.3
2.2
mg/l
3.2
3.0
1.30
574
4736
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
342
2533
1.40
7.32
1.8
1.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
37
138
2.70
7.25
1.3
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
15
30
5.02
7.18
1.7
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
45
188
2.42
7.02
1.3
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
33
118
2.82
7.00
5.6
3.8
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
121
723
1.70
6.97
2.2
2.4
g/l
1.0
1.2
0.18
106
632
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
46
197
2.36
6.80
2.5
2.4
—
—
—
0
0
(3020891) Body temperature
143
907
1.61
6.56
6.6
4.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
166
1092
1.55
6.52
3.4
2.6
%
1.3
1.2
0.44
166
1085
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
33
123
2.70
6.50
2.7
2.8
%
36.0
35.4
0.06
19
45
(3000060) B lymphocytes [#/volume] in Blood
16
37
4.34
6.49
1.4
2.0
e6/l
128.6
222.0
—
7
15
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
112
671
1.70
6.42
2.3
2.1
g/l
37.5
37.7
0.12
100
579
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
170
1137
1.53
6.20
1.7
1.7
g/l
1.7
1.5
1.34
144
968
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
102
603
1.72
6.15
1.6
1.6
iu/ml
21.2
12.8
0.14
17
119
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
128
804
1.62
6.13
2.5
2.3
g/l
3.1
3.1
0.06
105
640
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
161
1070
1.54
6.06
3.4
2.6
%
0.7
0.7
0.05
156
1029
(3043409) Potassium [Moles/volume] in Arterial blood
116
714
1.65
6.02
6.7
3.7
mmol/l
4.0
3.9
0.11
98
657
(3007164) IgA [Mass/volume] in Serum or Plasma
451
3600
1.30
5.85
1.6
1.5
g/l
2.9
2.6
0.56
278
2190
(3002385) Erythrocyte distribution width [Ratio]
1857
17274
1.22
5.77
32.3
17.8
%
14.1
13.7
15.42
1816
16857
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1934
20528
0.81
5.77
4.4
4.6
mmol/l
5.9
6.0
4.56
1736
18576
(40768441) Liver Pathology biopsy report
33
132
2.52
5.70
1.3
1.5
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
54
267
2.04
5.68
1.1
1.1
%
110.0
114.9
0.61
49
240
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
35
145
2.43
5.62
2.9
1.9
e6/l
627.1
705.1
0.26
14
66
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
65
345
1.91
5.60
1.1
1.1
u/ml
29.4
43.1
—
6
22
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
41
183
2.26
5.58
1.6
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
127
816
1.58
5.57
2.5
2.3
g/l
10.2
10.4
0.24
108
697
(3027273) Bicarbonate [Moles/volume] in Venous blood
166
1132
1.50
5.55
4.4
3.2
mmol/l
25.8
24.7
3.67
155
1092
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
99
598
1.68
5.55
1.4
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
68
368
1.87
5.53
1.7
1.4
u/ml
99.6
124.7
1.04
19
73
(3018851) Theophylline [Moles/volume] in Serum or Plasma
12
25
4.82
5.49
1.6
1.4
umol/l
49.8
48.6
0.04
12
25
(40768797) Stomach Pathology biopsy report
360
2823
1.32
5.30
1.4
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
18
53
3.41
5.30
2.9
1.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
37
163
2.29
5.21
1.1
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
601
7099
0.80
5.18
4.0
4.0
mg/mmol
15.5
8.8
1.71
408
4688
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
132
871
1.54
5.17
2.5
2.3
g/l
4.3
3.9
0.47
105
624
(21494814) CD8 cells/100 lymphocytes in Specimen
19
59
3.24
5.17
1.7
2.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
132
872
1.54
5.15
2.5
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
132
873
1.54
5.12
2.5
2.3
g/l
7.4
7.3
0.36
106
649
(3010503) CD19 cells [#/volume] in Blood
29
115
2.54
5.12
3.2
2.2
e9/l
0.4
0.2
0.65
29
109
(3014148) Varicella zoster virus Ab [Titer] in Serum
44
210
2.11
5.11
1.1
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
42
197
2.15
5.10
5.1
3.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
23
81
2.85
5.08
2.3
2.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
23
81
2.85
5.08
2.3
2.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
20
65
3.09
5.06
1.0
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
70
395
1.79
5.02
1.2
1.1
u/ml
12.8
5.2
—
7
26
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
11
23
4.80
5.01
1.3
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
82
485
1.71
5.00
1.3
1.2
u/ml
10.9
9.4
—
7
67
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
48
239
2.03
5.00
1.1
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
81
478
1.72
4.98
1.2
1.2
u/ml
1.3
2.3
—
7
34
(3027456) Digoxin [Moles/volume] in Serum or Plasma
78
456
1.73
4.96
3.5
3.0
nmol/l
0.9
0.8
0.52
64
345
(1761868) Lipid panel - Serum or Plasma
610
7154
0.81
4.87
2.9
2.9
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
88
536
1.66
4.82
1.3
1.4
u/l
9.6
7.9
0.67
66
443
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
20
67
3.00
4.82
1.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
38
176
2.18
4.78
1.7
2.8
%
10.4
11.2
0.42
38
176
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
28
114
2.47
4.71
1.6
1.4
u/ml
5.2
1.1
0.72
19
54
(3023520) Reticulocytes [#/volume] in Blood
263
2008
1.34
4.67
2.8
2.5
e9/l
67.5
68.0
0.07
193
1545
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
9
11
8.20
4.56
1.8
1.5
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
19
64
2.98
4.55
1.8
2.3
%
10.1
9.1
0.10
19
59
(3015171) Extractable nuclear Ab [Units/volume] in Serum
102
657
1.57
4.49
1.3
1.2
u/ml
3.6
0.4
—
9
55
(3003181) Sodium [Moles/volume] in Urine
62
350
1.79
4.48
1.5
1.3
mmol/l
55.1
64.6
1.04
41
284
(3028707) Methadone [Presence] in Urine by Screen method
54
292
1.87
4.47
2.7
3.2
—
—
—
0
0
(3004451) EKG impression Narrative
27
112
2.42
4.38
1.4
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
24
94
2.57
4.38
1.9
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2019
19131
1.20
4.36
27.7
15.8
%
38.8
40.0
6.60
1417
13249
(3025130) Human papilloma virus identified in Specimen
29
125
2.33
4.34
1.4
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
67
392
1.73
4.30
1.3
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
33
152
2.18
4.24
1.2
1.2
titre
320.0
169.1
—
5
32
(3012516) Albumin [Mass/volume] in Urine
577
6721
0.82
4.21
3.3
3.3
mg/l
646.5
272.5
0.92
405
4472
(4306422)
50
272
1.85
4.09
1.2
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
25
104
2.42
4.05
1.2
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
21
81
2.60
3.97
2.5
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
21
81
2.60
3.97
2.5
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
52
290
1.81
3.95
1.2
1.2
u/ml
1.5
4.4
1.51
20
102
(3023323) Follitropin [Units/volume] in Serum or Plasma
82
522
1.59
3.84
1.4
1.4
iu/l
22.5
25.7
0.43
71
444
(3001122) Ferritin [Mass/volume] in Serum or Plasma
957
8589
1.17
3.84
3.2
2.7
ug/l
211.7
152.7
3.15
879
7861
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
15
49
3.07
3.80
1.9
2.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
21
83
2.54
3.79
2.5
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
150
1086
1.40
3.75
1.3
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
527
4501
1.21
3.70
6.0
4.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
14
45
3.12
3.65
1.1
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
49
278
1.78
3.55
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
50
286
1.76
3.53
1.2
1.2
u/ml
3.1
5.4
0.94
21
131
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
10
26
3.86
3.52
1.1
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
125
1724
0.71
3.42
1.2
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
625
7107
0.84
3.39
3.1
3.3
mmol/l
7.7
7.9
0.63
531
5964
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
28
133
2.12
3.39
1.5
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
24
108
2.23
3.31
2.3
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
24
108
2.23
3.31
2.3
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
24
108
2.23
3.31
2.3
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
24
108
2.23
3.31
2.3
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
647
5685
1.18
3.29
1.3
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
2272
21921
1.19
3.29
30.2
17.3
mmol/l
139.1
139.7
21.11
2207
21330
(3011288) Drugs identified in Urine by Screen method
71
455
1.57
3.28
3.3
3.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1316
12208
1.15
3.23
3.1
2.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
2276
21977
1.19
3.20
30.3
17.5
mmol/l
4.0
4.0
0.52
2208
21352
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
11
33
3.34
3.19
1.5
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
34
180
1.90
3.09
1.2
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
46
268
1.73
3.09
2.4
2.0
mg/l
23.6
21.2
0.09
11
59
(3044242) Glucose [Moles/volume] in Arterial blood
27
132
2.06
3.06
2.0
2.2
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
11
34
3.24
3.05
1.2
1.3
ng/l
423.4
104.3
—
6
23
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
63
401
1.58
3.02
1.3
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
84
571
1.49
3.00
2.0
1.6
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
33
175
1.90
3.00
1.3
1.5
nmol/l
0.4
0.3
0.38
24
140
(40760888) Immunoglobulin light chains.free panel - Serum
79
531
1.50
2.98
3.0
3.6
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
43
249
1.74
2.96
7.3
8.0
mmol/l
7.8
7.8
0.01
38
208
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
797
8802
0.87
2.88
4.1
4.4
%
20.6
22.1
2.05
402
4388
(3026389) Candida sp identified in Specimen by Organism specific culture
40
229
1.76
2.87
1.4
1.4
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
49
298
1.66
2.84
2.8
2.1
—
4.0
—
0
5
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
218
1748
1.27
2.78
3.9
2.6
ml/min/173m2
65.0
65.0
0.00
95
708
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
19
84
2.27
2.77
1.1
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
196
1553
1.28
2.75
4.6
4.0
ng/l
93.9
96.7
0.16
172
1356
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
34
188
1.82
2.74
1.5
1.4
u/l
26.6
21.6
0.38
26
150
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
18
78
2.32
2.74
1.1
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
51
797
0.63
2.71
1.5
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
198
1576
1.28
2.69
2.3
2.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
481
5485
0.85
2.64
1.7
1.6
mmol/l
1.4
1.4
0.06
409
4592
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
15
61
2.47
2.62
1.3
2.4
e6/l
2665.3
29276.1
—
6
39
(3037756) Immunofixation for Serum or Plasma
71
482
1.49
2.60
1.8
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1016
10980
0.88
2.58
4.8
5.0
ug/l
5.1
3.9
0.40
902
9827
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
11
38
2.90
2.58
1.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
78
541
1.45
2.57
2.2
2.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
18
81
2.23
2.54
2.1
2.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
107
788
1.37
2.52
3.2
3.2
g/l
0.3
0.3
0.01
62
333
(3044889) 12 lead EKG panel
1586
15041
1.13
2.48
4.7
3.9
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
213
1732
1.25
2.44
5.6
3.5
mmol/l
1.2
1.2
0.92
204
1507
(40761536) Microorganisms panel - Urine sediment
212
1723
1.25
2.44
4.1
3.8
—
—
—
0
0
(3013512) EKG study
710
6415
1.14
2.43
4.8
4.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
84
601
1.41
2.36
1.3
1.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
17
4.13
2.36
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
168
2096
0.79
2.34
1.8
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1458
13789
1.12
2.33
4.0
3.1
u/l
60.7
53.9
1.23
1351
12801
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
37
222
1.68
2.31
2.1
1.7
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
96
707
1.37
2.29
3.5
3.4
mg/l
36.7
55.7
1.23
75
579
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
94
690
1.37
2.29
3.5
3.4
ratio
1.3
2.7
—
8
54
(3022493) Free Hemoglobin [Mass/volume] in Plasma
18
85
2.12
2.28
1.6
3.4
mg/l
66.8
62.6
0.11
13
63
(3034860) Kappa light chains.free [Mass/volume] in Serum
96
708
1.37
2.27
3.5
3.4
mg/l
90.9
63.1
0.31
77
579
(3009871) Measles virus Ab [Titer] in Serum
12
47
2.56
2.27
1.4
1.6
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
8
23
3.49
2.27
1.1
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
40
247
1.63
2.25
1.9
1.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
29
3.11
2.22
1.0
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
9
29
3.11
2.22
1.8
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
40
248
1.62
2.22
1.9
1.4
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
5
9
5.56
2.21
1.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
90
661
1.37
2.20
2.2
2.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
95
704
1.36
2.19
2.1
2.3
—
—
—
0
0
(3015736) pH of Urine
864
7958
1.12
2.15
3.6
3.3
—
5.9
—
0
7
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
9
30
3.01
2.14
11.0
9.8
mmol/l
5.5
6.1
—
9
30
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
56
379
1.49
2.13
1.3
1.2
u/ml
329.7
268.0
0.54
31
234
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
15
68
2.21
2.11
4.3
2.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
95
710
1.35
2.09
2.1
2.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
16
75
2.14
2.08
3.4
2.3
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
7
20
3.51
2.05
1.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
95
713
1.34
2.04
2.1
2.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
12
50
2.41
2.02
3.6
2.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
39
247
1.59
2.01
1.9
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
129
1014
1.29
2.00
3.7
3.4
pmol/l
4.1
4.5
3.64
112
889
(3049717) Cytology report of Urine Cyto stain
134
1059
1.28
2.00
2.8
2.8
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
15
70
2.15
1.98
3.5
2.4
ug/l
16.9
482.9
0.70
15
61
(3023487) Leukocytes [#/volume] in Peritoneal fluid
15
70
2.15
1.98
1.9
2.9
e6/l
294.4
645.5
—
7
56
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
351
3059
1.17
1.98
1.3
1.2
iu/ml
37.8
32.5
0.30
96
928
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
60
419
1.44
1.97
2.0
1.8
iu/l
3.1
4.4
0.39
11
140
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
35
217
1.62
1.97
1.4
1.3
nmol/l
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
75
546
1.38
1.96
1.6
1.6
e6/l
15257.9
13961.8
0.08
47
383
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
37
235
1.58
1.90
1.2
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
39
251
1.56
1.89
1.9
1.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
25
143
1.75
1.89
1.2
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
12
52
2.31
1.87
1.0
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
39
252
1.56
1.87
1.9
1.4
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
19
100
1.91
1.85
1.1
1.2
ratio
1.1
1.1
—
10
26
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
19
100
1.91
1.85
2.5
2.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
138
1107
1.26
1.84
2.3
2.4
—
—
—
0
0
(44813793)
20
108
1.86
1.81
1.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
12
53
2.27
1.80
1.2
2.7
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
35
2.58
1.80
1.0
2.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
44
295
1.50
1.80
2.8
2.4
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
8
29
2.76
1.79
1.0
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2054
19932
1.11
1.78
23.8
13.9
ml/min/173m2
81.9
79.1
6.62
1791
16463
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
20
109
1.84
1.77
1.4
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
38
248
1.54
1.76
1.9
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
41
2.44
1.75
1.2
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
48
330
1.46
1.74
1.4
1.2
—
—
—
0
0
(4281824)
25
147
1.71
1.74
1.6
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
56
397
1.42
1.74
1.3
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
867
8072
1.11
1.73
2.6
2.2
nmol/l
75.3
76.7
0.66
764
7167
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
81
612
1.33
1.71
1.5
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
529
4802
1.13
1.67
3.7
3.5
—
—
—
0
0
(4034850)
47
667
0.70
1.66
20.1
10.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
38
252
1.51
1.65
1.3
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
17
90
1.89
1.65
1.1
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
60
436
1.38
1.63
1.7
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
90
697
1.30
1.62
2.0
2.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
14
3.58
1.61
1.2
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
14
3.58
1.61
1.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
5
14
3.58
1.61
1.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
186
0.48
1.61
1.1
1.5
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
39
262
1.50
1.60
1.5
1.5
pmol/l
187.5
235.0
0.21
39
257
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
13
63
2.07
1.59
10.9
7.5
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
34
222
1.54
1.59
1.5
1.3
e6/l
14729.5
98822.2
1.36
25
158
(3025315) Body weight
6
20
3.00
1.58
5.2
3.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
70
525
1.34
1.58
4.2
3.1
mmol/l
1.5
1.7
1.11
70
512
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
22
129
1.71
1.56
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
22
129
1.71
1.56
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
22
129
1.71
1.56
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
581
6321
0.90
1.54
2.9
3.1
ug/l
0.8
0.8
0.31
397
4284
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
24
145
1.66
1.54
1.0
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1075
10166
1.09
1.52
5.5
4.8
estimate
0.0
0.0
0.50
222
1882
(3016650) Hepatitis A virus Ab [Presence] in Serum
46
324
1.43
1.51
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
96
758
1.28
1.51
2.3
2.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
21
123
1.71
1.50
1.1
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
168
0.47
1.46
1.1
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
27
415
0.65
1.46
1.3
1.5
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
22
132
1.67
1.46
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
22
132
1.67
1.46
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
22
132
1.67
1.46
1.0
1.1
—
—
—
0
0
(4268621)
30
195
1.54
1.45
2.5
2.3
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
28
2.50
1.45
1.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
32
212
1.52
1.43
1.4
1.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
26
164
1.59
1.43
1.8
1.5
promille
1.6
1.2
0.71
21
128
(3035933) Granulocytes/100 leukocytes in Blood
9
39
2.31
1.43
1.0
1.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
30
196
1.54
1.43
1.2
1.2
u/l
77.5
54.5
0.67
20
133
(3024263) Appearance of Synovial fluid
23
141
1.64
1.41
1.5
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1073
10176
1.09
1.40
4.0
3.5
estimate
0.0
0.0
0.50
219
1840
(3009261) Glucose [Presence] in Urine by Test strip
1085
10295
1.09
1.39
4.0
3.6
estimate
0.0
0.0
0.80
215
1795
(3000570) Elastase.pancreatic [Mass/mass] in Stool
76
590
1.30
1.38
1.4
1.5
ug/g
253.2
273.3
0.37
44
350
(3019309) Folate [Moles/volume] in Red Blood Cells
481
4392
1.11
1.38
1.8
1.8
nmol/l
1112.7
1160.9
0.45
362
3311
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
20
119
1.69
1.37
3.7
3.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
64
486
1.32
1.36
4.4
3.2
mmol/l
6.9
7.6
1.70
64
475
(3006922) Hepatitis E virus Ab [Presence] in Serum
21
127
1.66
1.36
1.0
1.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
5
17
2.94
1.36
1.0
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
53
709
0.74
1.35
1.7
1.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
291
2580
1.14
1.35
1.8
1.8
%
1.7
1.5
2.05
241
2279
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
76
592
1.29
1.35
1.3
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
113
1.69
1.31
1.1
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
17
98
1.74
1.31
4.5
2.7
u/ml
4299.8
1205.5
0.58
17
98
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
17
98
1.74
1.31
1.5
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
17
98
1.74
1.31
1.5
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
12
62
1.94
1.27
1.4
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
11
55
2.00
1.27
4.3
7.7
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
20
122
1.64
1.27
2.4
3.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
76
598
1.28
1.27
1.3
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
25
375
0.66
1.24
1.5
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
15
85
1.77
1.23
1.5
1.6
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
19
2.63
1.21
1.4
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
19
2.63
1.21
1.4
1.1
—
—
—
0
0
(4027681)
19
116
1.64
1.21
1.4
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
76
603
1.27
1.20
1.3
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
34
238
1.43
1.20
1.3
1.4
pmol/l
529.2
267.0
0.33
29
183
(3051593) INR in Capillary blood by Coagulation assay
18
109
1.66
1.18
8.0
16.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
54
410
1.32
1.18
1.8
1.5
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
39
2.05
1.15
1.0
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
20
126
1.59
1.14
1.6
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
20
126
1.59
1.14
1.4
2.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
46
609
0.75
1.14
2.3
2.3
ug/min
80.9
90.1
0.07
27
371
(3044290) Cell count panel - Cerebral spinal fluid
55
422
1.31
1.13
1.3
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
8
40
2.00
1.12
1.9
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
43
319
1.35
1.11
1.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
41
302
1.36
1.11
1.3
1.2
—
—
—
0
0
(1002224) Polysomnography panel
65
818
0.79
1.10
1.1
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
16
96
1.67
1.10
1.5
3.1
umol/l
83.8
115.9
—
10
61
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
21
2.38
1.09
1.0
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
8
41
1.95
1.08
1.5
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
20
128
1.57
1.08
1.7
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
562
5243
1.09
1.06
1.7
1.6
nmol/l
19.5
19.9
0.19
487
4469
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
41
305
1.35
1.05
2.9
2.7
u/ml
4.0
174.5
0.68
41
294
(3023511) Choriogonadotropin [Units/volume] in Urine
28
195
1.44
1.04
1.1
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
21
138
1.53
1.02
1.6
1.5
g/l
0.9
1.0
0.98
21
138
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
36
485
0.74
1.02
1.3
1.7
nmol/l
1.0
0.8
0.66
26
402
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
19
122
1.56
1.02
1.5
1.6
u/l
3.0
6.7
—
7
59
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
9
47
1.92
1.02
1.1
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
259
2331
1.12
1.00
1.4
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
28
197
1.43
1.00
1.1
1.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
58
458
1.27
0.99
1.3
1.3
miu/ml
185.2
227.8
0.27
17
193
(40761511) CBC panel - Blood by Automated count
2228
21900
1.08
0.99
23.7
13.9
—
—
—
0
0
(4146454)
16
249
0.64
0.99
1.8
2.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
74
603
1.23
0.97
2.4
1.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
162
1417
1.15
0.97
1.1
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
10
54
1.85
0.96
1.0
1.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
49
381
1.29
0.95
2.3
2.5
u/l
863.3
3375.3
1.12
20
147
(4133840)
9
52
1.73
0.92
1.1
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
319
2921
1.10
0.91
1.2
1.2
u/ml
25.0
11.4
1.23
104
1120
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
28
2.15
0.91
1.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
47
366
1.29
0.91
1.5
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
126
1.51
0.91
1.1
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
19
278
0.68
0.89
1.3
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
29
211
1.38
0.88
1.2
1.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
10
56
1.79
0.87
2.3
2.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
10
56
1.79
0.87
2.5
2.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
14
87
1.61
0.87
1.1
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
30
2.00
0.87
1.2
1.3
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
8
44
1.82
0.85
1.5
1.8
mmol/l
1.2
1.2
—
8
44
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
8
44
1.82
0.85
4.4
7.8
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
18
120
1.50
0.85
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
18
120
1.50
0.85
1.1
1.0
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
21
145
1.45
0.84
1.1
1.4
—
176.3
—
0
16
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
6
31
1.94
0.84
1.8
1.7
ng/l
111.7
154.0
—
6
31
(3007566) Smooth muscle Ab [Titer] in Serum
65
533
1.22
0.84
1.3
1.2
titre
74.0
87.9
—
5
52
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
93
1089
0.85
0.82
1.6
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
8
46
1.74
0.82
1.0
1.3
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
32
1.88
0.81
1.0
1.2
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
6
32
1.88
0.81
1.5
2.8
—
26.5
—
0
6
(3019832) Treponema pallidum Ab [Presence] in Serum
151
1339
1.13
0.78
1.8
1.7
—
—
—
0
0
(3019225) pH of Specimen
239
2178
1.11
0.78
5.8
4.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
29
217
1.34
0.76
1.3
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
33
252
1.31
0.76
1.3
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
34
1.77
0.76
1.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
15
99
1.52
0.75
1.1
1.3
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
13
83
1.57
0.75
1.0
1.2
—
0.1
—
0
6
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
24
2.09
0.74
1.0
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
121
1063
1.14
0.73
1.2
1.2
iu/ml
151.6
152.9
0.01
40
393
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
25
334
0.75
0.73
1.5
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
59
488
1.21
0.73
1.4
1.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
84
719
1.17
0.72
1.1
1.1
—
1.5
—
0
11
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
10
60
1.67
0.72
1.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
105
915
1.15
0.72
1.2
1.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
17
117
1.46
0.71
1.5
1.6
u/field
0.8
4.0
1.29
12
82
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
11
68
1.62
0.71
1.2
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
26
1.92
0.70
1.2
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
26
1.92
0.70
1.2
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
26
1.92
0.70
1.2
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
30
230
1.31
0.69
1.9
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
13
85
1.53
0.69
1.2
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
85
1.53
0.69
1.8
2.6
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
12
77
1.56
0.68
4.9
3.6
%
57.6
55.6
0.16
12
72
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
5
27
1.85
0.68
1.2
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
69
1.60
0.68
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
43
1.63
0.66
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
43
1.63
0.66
1.0
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
7
43
1.63
0.66
1.3
1.5
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
43
1.63
0.66
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
43
1.63
0.66
1.0
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
28
1.79
0.66
1.0
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
28
1.79
0.66
1.0
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
28
1.79
0.66
1.8
2.3
—
—
—
0
0
(3001729) Color of Synovial fluid
5
28
1.79
0.66
1.6
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
151
1676
0.90
0.66
1.9
1.8
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
7
44
1.59
0.65
1.3
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
44
1.59
0.65
1.1
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
41
331
1.24
0.65
4.2
3.3
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
28
215
1.31
0.65
1.4
1.4
pmol/l
53.5
202.5
—
8
69
(3003338) MCHC [Mass/volume]
1811
17783
1.05
0.64
33.3
19.1
g/l
331.1
333.3
18.69
1785
17615
(3013139) Helicobacter pylori Ag [Presence] in Stool
111
1251
0.88
0.63
1.1
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
12
79
1.52
0.62
1.2
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
32
252
1.27
0.62
1.1
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
103
0.58
0.62
3.2
7.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
154
1393
1.11
0.61
2.6
3.0
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
14
96
1.46
0.61
1.1
1.0
iu/ml
5.2
11.1
—
6
29
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
68
582
1.17
0.61
1.7
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
21
156
1.35
0.61
1.1
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
57
481
1.19
0.60
1.2
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
10
64
1.56
0.58
1.0
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
257
2760
0.92
0.58
10.9
7.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
23
175
1.32
0.58
1.1
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
155
1411
1.10
0.56
3.5
3.3
e9/l
4.3
4.2
0.18
114
1070
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1843
18720
0.95
0.56
4.7
4.3
mu/l
2.5
2.1
0.30
1648
16948
(3032773) Endomysium IgG Ab [Titer] in Serum
20
150
1.34
0.55
1.1
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
37
1.62
0.55
1.0
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
70
607
1.16
0.55
1.9
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
447
4696
0.94
0.54
1.8
1.7
pmol/l
441.1
25232859.6
3.22
368
3872
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
16
116
1.38
0.54
1.0
1.0
u/l
1.4
1.2
—
6
60
(3039443) Prostate specific Ag panel - Serum or Plasma
48
568
0.84
0.54
1.4
1.7
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
60
1.50
0.54
1.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
30
240
1.25
0.53
2.1
2.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
162
1767
0.91
0.53
1.4
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
62
1.45
0.53
1.3
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
12
83
1.45
0.51
1.4
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
65
1.39
0.50
1.0
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
241
2255
1.08
0.49
2.1
2.4
ug/g
300.5
152.1
0.88
192
1791
(3051387) C reactive protein [Mass/volume] in Capillary blood
59
511
1.16
0.49
4.2
3.4
mg/l
45.7
30.8
1.20
37
318
(3017446) Testosterone [Moles/volume] in Serum or Plasma
239
2237
1.07
0.48
2.3
2.2
nmol/l
13.8
13.0
0.66
207
1965
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
11
76
1.45
0.48
1.0
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
766
7906
0.96
0.47
4.4
3.7
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
7
47
1.49
0.47
1.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
10
68
1.47
0.47
1.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
21
266
0.79
0.46
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
79
887
0.89
0.46
1.1
1.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
16
120
1.34
0.46
1.1
1.4
nmol/l
1.5
1.1
0.51
11
92
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
7
49
1.43
0.46
1.4
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
70
618
1.14
0.45
4.2
4.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
77
1.43
0.45
1.0
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
29
238
1.22
0.44
1.1
1.0
u/ml
2.6
2.9
0.08
12
99
(3006462) Nitrate [Presence] in Urine
13
95
1.37
0.43
2.5
3.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
172
1599
1.08
0.43
2.0
1.9
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
35
295
1.19
0.41
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
35
295
1.19
0.41
1.1
1.1
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.4
—
5.1
—
0
15
(3029075) Extractable nuclear Ab panel - Serum
8
59
1.36
0.41
1.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
31
369
0.84
0.40
1.1
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.0
—
0.1
—
0
12
(3004775) Volume in Urine collected for unspecified duration
16
203
0.79
0.38
1.7
2.2
ml
673.3
623.7
—
10
123
(3038177) Helicobacter pylori Ab [Presence] in Serum
35
299
1.17
0.37
1.2
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
567
5492
1.04
0.36
4.0
3.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
187
1759
1.07
0.36
2.1
2.0
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2272
22545
1.04
0.36
30.0
17.3
umol/l
82.8
83.5
0.29
2272
22538
(3000285) Sodium [Moles/volume] in Blood
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1489
15106
0.97
0.35
4.1
3.6
pmol/l
14.9
14.9
0.32
1331
13580
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
54
481
1.13
0.34
1.2
1.2
mmol/l
3.7
3.8
0.41
47
446
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
54
481
1.13
0.34
1.1
1.1
u/ml
3.4
7.8
—
6
49
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
45
1.33
0.33
1.2
1.0
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
53
472
1.13
0.33
1.3
1.3
e6/l
5.2
28.2
1.11
36
373
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
53
472
1.13
0.33
1.4
1.4
e6/l
1393.1
779.7
0.25
39
387
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
46
1.30
0.33
1.5
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
60
540
1.11
0.32
1.3
1.3
mg/l
730.1
549.5
0.32
54
503
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
30
348
0.86
0.31
1.1
1.1
iu/ml
141.0
93.3
0.18
12
75
(4094501)
53
590
0.90
0.31
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
21
251
0.84
0.31
1.1
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
419
4051
1.04
0.31
1.3
1.2
u/ml
1.6
1.6
0.01
85
1080
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
53
1.32
0.30
1.0
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
26
221
1.18
0.30
1.9
1.4
%
36.6
28.1
0.57
21
138
(4198724)
11
84
1.31
0.30
1.4
1.9
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
61
671
0.91
0.29
1.2
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
255
2661
0.95
0.29
3.9
4.5
%
32.9
32.1
0.48
178
1791
(1617658) Protocol used for examination of sentinel lymph nodes
8
106
0.75
0.29
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
8
62
1.29
0.28
1.4
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
21
247
0.85
0.27
1.2
1.3
mmol/l
7.1
7.5
0.36
15
178
(40768793) Breast Pathology biopsy report
26
300
0.87
0.26
1.4
1.3
—
—
—
0
0
(4211845)
13
105
1.24
0.24
2.5
3.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
20
234
0.85
0.24
1.1
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
12
96
1.25
0.24
1.0
1.2
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
11
87
1.27
0.24
1.2
1.2
%
58.9
60.0
0.04
11
76
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
84
0.71
0.24
1.0
1.0
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
5
40
1.25
0.22
2.2
1.4
ug/l
112.4
121.9
—
5
35
(3019150) Specific gravity of Urine by Refractometry
450
4611
0.97
0.22
4.5
3.9
kg/l
1.0
1.0
0.79
62
682
(3045424) Erythrocytes [Presence] in Urine
32
357
0.90
0.21
1.5
1.4
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
7.4
—
0
11
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
0.4
—
0
6
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
10
0.00
0.21
0.0
6.3
—
423.8
—
0
10
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
25.2
—
0
5
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
31
346
0.89
0.21
1.8
1.6
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.2
—
34.2
—
0
5
(3020961) Endomysium IgA Ab [Titer] in Serum
86
808
1.07
0.21
1.1
1.1
—
146.4
—
0
15
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
0.1
—
0
8
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
14
0.00
0.20
0.0
3.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
6
48
1.25
0.20
1.0
1.0
—
3.2
—
0
6
(3005033) Fetal Nuchal fold Thickness US
21
183
1.15
0.20
1.2
1.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
16
186
0.86
0.19
1.3
1.1
u/ml
4.6
2.6
0.26
11
73
(3047352) Trisomy 18 risk [Likelihood] in Fetus
21
184
1.14
0.19
1.2
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
17
196
0.87
0.18
1.5
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
18
206
0.87
0.18
1.2
1.0
u/ml
6.0
1.5
0.58
11
80
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
5
67
0.75
0.17
2.2
3.6
mg/l
10.7
7.6
—
5
57
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
68
0.73
0.17
1.4
1.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
64
680
0.94
0.16
2.9
1.7
mg/l
12.5
2.9
1.65
46
478
(3026361) Erythrocytes [#/volume] in Blood
2343
23518
0.98
0.16
37.3
21.5
e12/l
4.4
4.5
29.50
2265
22771
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
22
196
1.12
0.16
1.4
1.9
u/field
2.8
1.9
—
9
68
(3029937) Albumin [Presence] in Urine by Test strip
564
5547
1.02
0.16
4.4
3.9
estimate
0.0
0.0
1.08
199
1761
(3000963) Hemoglobin [Mass/volume] in Blood
2344
23526
0.98
0.16
37.5
21.6
g/l
132.1
136.9
37.96
2303
23103
(3035941) MCH [Entitic mass]
2343
23516
0.98
0.16
37.1
21.4
pg
30.4
30.4
0.70
2299
23098
(3024731) MCV [Entitic volume]
2343
23516
0.98
0.16
37.2
21.4
fl
91.6
91.2
4.46
2299
23098
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
18
159
1.13
0.15
1.3
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
21
188
1.12
0.14
1.4
1.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
2345
23528
0.98
0.14
37.3
21.5
e9/l
7.5
6.8
18.78
2265
22780
(3045414) Leukocytes [Presence] in Urine
87
909
0.96
0.13
1.9
1.9
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
22
199
1.11
0.13
1.1
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2343
23503
0.98
0.13
37.3
21.5
e9/l
254.4
240.6
17.06
2269
22833
(3036603) Volume of Urine
15
132
1.14
0.13
1.5
1.4
ml
2381.2
1722.1
—
5
33
(3010838) Calcium [Moles/time] in 24 hour Urine
11
94
1.17
0.13
1.3
1.6
—
11.1
—
0
6
(3010726) Horse dander IgE Ab [Units/volume] in Serum
22
242
0.91
0.13
1.2
1.1
u/ml
1.5
1.6
—
8
57
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2261
22535
1.02
0.12
15.4
10.2
u/l
25.6
27.6
6.16
2190
21658
(3042111) Morphology [Interpretation] in Bone marrow Narrative
42
394
1.07
0.12
1.6
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
63
600
1.05
0.12
1.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
15
133
1.13
0.12
1.9
1.6
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
11
95
1.16
0.11
1.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
11
95
1.16
0.11
1.1
1.1
iu/ml
152.7
195.4
0.28
11
95
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
13
147
0.88
0.11
1.5
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
599
5920
1.02
0.11
4.1
2.7
umol/l
3780.5
5876.1
0.67
508
5110
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
126
0.87
0.11
1.1
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
126
0.87
0.11
1.1
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
44
465
0.95
0.11
2.2
2.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
31
289
1.07
0.11
1.2
1.1
u/ml
3.7
1.8
0.30
15
118
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
46
1.09
0.09
1.0
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
13
116
1.12
0.09
1.9
1.6
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
6
56
1.07
0.08
1.0
1.1
pmol/l
233.2
254.0
—
6
41
(3035320) C reactive protein [Mass/volume] in Body fluid
15
136
1.10
0.08
2.9
2.3
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
5
61
0.82
0.08
2.0
3.0
—
90.0
—
0
13
(4024509)
17
185
0.92
0.08
2.3
1.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
63
0.79
0.08
1.0
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
114
1112
1.03
0.08
4.2
3.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
75
1.07
0.07
3.0
2.3
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
7
80
0.87
0.07
3.6
2.2
nmol/l
148.6
147.6
—
7
69
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
28
265
1.06
0.07
2.1
1.5
%
47.6
61.8
1.05
18
162
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
39
406
0.96
0.06
1.2
1.2
u/l
24.4
47.3
1.45
28
362
(3000034) Microalbumin [Mass/volume] in Urine
20
213
0.94
0.06
2.7
3.2
mg/l
105.5
26.8
0.62
13
172
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
131
0.92
0.05
2.1
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
131
0.92
0.05
2.1
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
137
1349
1.02
0.05
2.3
2.4
au/ml
38.6
20.5
—
5
62
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
23
242
0.95
0.05
1.4
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
22
231
0.95
0.04
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
22
231
0.95
0.04
1.2
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
92
936
0.98
0.04
1.5
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
188
1861
1.01
0.04
4.1
3.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
303
3008
1.01
0.03
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
22
230
0.96
0.03
1.2
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
22
230
0.96
0.03
1.2
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
21
218
0.96
0.02
1.2
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
11
103
1.07
0.02
1.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
11
103
1.07
0.02
1.4
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
23
223
1.03
0.01
1.7
1.9
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
27
263
1.03
0.01
1.0
1.1
u/ml
10.4
5.3
—
10
144
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
122
1212
1.01
0.01
1.3
1.3
au/ml
48.4
56.1
—
8
52
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
158
1588
0.99
0.01
1.3
1.4
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
11
104
1.06
0.01
2.3
1.3
%
2.2
3.3
—
6
24
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
70
694
1.01
0.00
1.5
1.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
12
119
1.01
0.00
1.2
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
14
136
1.03
0.00
3.0
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
901
9015
1.00
0.00
2.2
2.0
pmol/l
91.4
93.0
0.46
514
4890
(3000012) Reticulocyte production index
11
112
0.98
0.00
1.2
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
10
97
1.03
0.00
1.4
1.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
25
253
0.99
0.00
1.0
1.1
u/ml
0.3
1.8
—
10
111
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
87
0.92
0.00
1.0
1.1
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
7
78
0.90
0.00
4.6
5.6
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
1745.2
—
0
5
(40761995) Spermatozoa Progressive [#/volume] in Semen
7
78
0.90
0.00
2.3
2.8
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
6
64
0.94
0.00
1.2
2.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
5
0.00
0.00
0.0
8.0
—
74.8
—
0
5
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
5
52
0.96
0.00
1.8
2.2
mmol/l
7.7
7.7
—
5
29
(3044336) Cobalt [Moles/volume] in Urine
0
5
0.00
0.00
0.0
2.0
—
16.4
—
0
5
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
8
79
1.01
0.00
1.1
1.1
miu/ml
1102.3
1575.4
—
8
79
(3036180) Methadone [Presence] in Urine
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(40758358) Immune stain study
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
7
0.00
-0.00
0.0
4.6
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
-0.00
0.0
2.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint J10_PNEUMOTHORAX and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| J10_PNEUMOTHORAX | 3.635 [3.02, 4.38] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.272 |
During the follow-up period (1.1.1998 — 31.12.2019), 1318 out of 3535 females with J10_PNEUMOTHORAX died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| J10_PNEUMOTHORAX | 3.073 [2.67, 3.54] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.011 |
During the follow-up period (1.1.1998 — 31.12.2019), 3115 out of 8847 males with J10_PNEUMOTHORAX died.
Mortality risk
Mortality risk for people of age
years, who have J10_PNEUMOTHORAX.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.378% | 0.728% |
| 5 | 2.178% | 3.226% |
| 10 | 5.309% | 8.486% |
| 15 | 9.927% | 15.785% |
| 20 | 16.779% | 25.869% |
Relationships between endpoints
↥Index endpoint: J10_PNEUMOTHORAX – Pneumothorax
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data